Lead
Gayn Erickson, the president and chief executive officer of Aehr Test Systems (NASDAQ: AEHR), executed a large sale of company stock in April 2026 while the shares were trading near their 52-week high.
Insider transactions
According to a Form 4 filing with the Securities and Exchange Commission, Erickson sold 152,824 shares of common stock on April 10, 2026, at a per-share price of $70.5831, generating approximately $10.7 million in proceeds. The filing further shows that on April 11, 2026, he disposed of 3,704 additional shares to cover tax obligations; that transaction occurred at $70.43 per share and totaled $260,872.
The sale filings were submitted through Erickson's attorney-in-fact, Chris Siu.
Post-sale holdings
After these transactions, Erickson is reported to directly own 191,999 shares of Aehr Test Systems. That reported total includes shares that remain subject to unvested restricted stock units and unvested restricted shares. In addition to his direct holdings, he indirectly holds 197,723 shares in a trust.
Share performance context
The insider sales came as Aehr Test Systems' shares were trading close to a 52-week high of $74.53, following an extraordinary 763% increase in the prior 12 months.
Company financials and demand indicators
In other filings and disclosures, Aehr Test Systems reported mixed third-quarter results for fiscal 2026. The company recorded diluted earnings per share of -$0.05, outperforming analysts' consensus of -$0.07. Revenue for the quarter was $10.3 million, short of the $10.8 million that analysts had expected.
Offsetting the revenue shortfall, Aehr Test Systems posted record quarterly bookings of $37.2 million and said its backlog exceeded $50 million. Analysts cited the company's strong bookings momentum and an elevated book-to-bill ratio as important demand signals.
Analyst adjustments
Following the results and bookings update, Freedom Broker raised its price target on Aehr Test Systems from $38.00 to $61.00 while maintaining a Hold rating. Lake Street also lifted its target, increasing it to $56 from $50, and referenced the robust bookings and a book-to-bill ratio above 3.5x.
Takeaway
The April insider sales, disclosed via Form 4 filings, occurred against a backdrop of mixed quarterly operating results but strong near-term demand indicators for Aehr Test Systems. Erickson's reported holdings now comprise both direct and indirect positions, some of which include unvested restricted shares.